Use of cardioprotective glucose lowering therapy before and after myocardial infarction among patients with type-2 diabetes: a nationwide registry study
1 September 2025 (14:15 - 15:00)
Organised by: 
About the speaker
Lund University, Malmo (Sweden)
4 More presentations in this session
Doctor T. Andersson (Gothenburg, SE)
Doctor E. Mansouri (Tehran, IR)
Mr L. Barbosa (Belo Horizonte, BR)
Doctor J. Isufi (Gothenburg, SE)
Access the full session
The Event
ESC Congress 2025
1 September 2025
14:15 CET
